Abstract

The mechanisms of lung cancer are highly complex. Not only mRNA gene expression but also microRNAs, DNA methylation, and copy number variation (CNV) play roles in tumorigenesis. It is difficult to incorporate so much information into a single model that can comprehensively reflect all these lung cancer mechanisms. In this study, we analyzed the 129 TCGA (The Cancer Genome Atlas) squamous cell lung carcinoma samples with gene expression, microRNA expression, DNA methylation, and CNV data. First, we used variance inflation factor (VIF) regression to build the whole genome integrative network. Then, we isolated the lung cancer subnetwork by identifying the known lung cancer genes and their direct regulators. This subnetwork was refined by the Bayesian method, and the directed regulations among mRNA genes, microRNAs, methylations, and CNVs were obtained. The novel candidate key drivers in this refined subnetwork, such as the methylation of ARHGDIB and HOXD3, microRNA let-7a and miR-31, and the CNV of AGAP2, were identified and analyzed. On three large public available lung cancer datasets, the key drivers ARHGDIB and HOXD3 demonstrated significant associations with the overall survival of lung cancer patients. Our results provide new insights into lung cancer mechanisms.

Highlights

  • Lung cancer is the most common cause of cancer-related death worldwide, and non-small-cell lung cancer (NSCLC) accounts for approximately 80% of all cases [1]

  • In squamous cell lung carcinoma (SCC), aberrant amplification or expression of FGFR1 and IGF1R leads to the dysfunction of downstream signaling via the PI3K/AKT and RAS/MEK pathways [28,29,30,31,32]

  • We identified some novel genes and miRNAs involved in SCC pathogenesis and some known genes or factors that were previously neglected and should receive more attention

Read more

Summary

Introduction

Lung cancer is the most common cause of cancer-related death worldwide, and non-small-cell lung cancer (NSCLC) accounts for approximately 80% of all cases [1]. Many studies have provided insight into several driver genes, miRNAs, and crucial signaling pathways that contribute to lung cancer pathogenesis. The PI3K-AKT and RAS-RAF-MEK-ERK signaling pathways play central roles in antiapoptosis and proliferation in many cancers, including SCC [13,14,15]. In SCC, aberrant amplification or expression of FGFR1 and IGF1R leads to the dysfunction of downstream signaling via the PI3K/AKT and RAS/MEK pathways [28,29,30,31,32]. The target genes regulated by miRNAs have been demonstrated to play critical roles in cancer pathogenesis [42,43,44,45]. We collect SCC related genes from the hsa05225 pathway (non-small-cell lung cancer, Homo sapiens) in KEGG and obtained the regulatory factors, as discussed above. We identified some novel genes and miRNAs involved in SCC pathogenesis and some known genes or factors that were previously neglected and should receive more attention

Methods
Results and Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call